...
首页> 外文期刊>BMC Medical Genetics >Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM
【24h】

Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM

机译:LD-PCR,DHPLC,多重PCR检测台湾人群122例血友病A族的突变谱并评估HRM的临床应用

获取原文
           

摘要

Background Hemophilia A represents the most common and severe inherited hemorrhagic disorder. It is caused by mutations in the F8 gene, which leads to a deficiency or dysfunctional factor VIII protein, an essential cofactor in the factor X activation complex. Methods We used long-distance polymerase chain reaction and denaturing high performance liquid chromatography for mutation scanning of the F8 gene. We designed the competitive multiplex PCR to identify the carrier with exonal deletions. In order to facilitate throughput and minimize the cost of mutation scanning, we also evaluated a new mutation scanning technique, high resolution melting analysis (HRM), as an alternative screening method. Results We presented the results of detailed screening of 122 Taiwanese families with hemophilia A and reported twenty-nine novel mutations. There was one family identified with whole exons deletion, and the carriers were successfully recognized by multiplex PCR. By HRM, the different melting curve patterns were easily identified in 25 out of 28 cases (89%) and 15 out of 15 (100%) carriers. The sensitivity was 93 % (40/43). The overall mutation detection rate of hemophilia A was 100% in this study. Conclusion We proposed a diagnostic strategy for hemophilia A genetic diagnosis. We consider HRM as a powerful screening tool that would provide us with a more cost-effective protocol for hemophilia A mutation identification.
机译:背景A型血友病是最常见和最严重的遗传性出血性疾病。它是由F8基因突变引起的,该突变导致VIII因子蛋白缺乏或功能失调,而VIII蛋白是X因子激活复合物中必不可少的辅助因子。方法采用长距离聚合酶链反应和变性高效液相色谱法对F8基因进行突变扫描。我们设计了竞争性多重PCR,以鉴定具有外显子缺失的载体。为了提高通量并最小化突变扫描的成本,我们还评估了一种新的突变扫描技术,即高分辨率熔解分析(HRM),作为替代筛选方法。结果我们介绍了对122个台湾血友病A族进行详细筛选的结果,并报告了29个新突变。鉴定出一个具有全外显子缺失的家族,并且通过多重PCR成功地识别了载体。通过HRM,在28个案例中的25个(89%)和15个案例(100%)中的15个很容易识别出不同的熔解曲线模式。灵敏度为93%(40/43)。本研究中血友病A的总体突变检出率为100%。结论我们提出了血友病A基因诊断的诊断策略。我们认为HRM是一种功能强大的筛选工具,可为我们提供更具成本效益的血友病A突变鉴定方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号